Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q410040> ?p ?o }
Showing triples 1 to 24 of
24
with 100 triples per page.
- Q410040 subject Q8431759.
- Q410040 subject Q9622264.
- Q410040 abstract "Forodesine (INN; also known as Immucillin H) is a transition-state analog inhibitor of purine nucleoside phosphorylase under development for the treatment of relapsed B-cell chronic lymphocytic leukemiaImmucillin H was originally discovered by Vern Schramm's laboratory at the Albert Einstein College of Medicine in New York and Industrial Research Limited in New Zealand.Forodesine is being developed by BioCryst Pharmaceuticals as Fodosine. As of 2008, it is currently in phase II clinical trials.".
- Q410040 iupacName "7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-1,5-dihydropyrrolo[2,3-e]pyrimidin-4-one".
- Q410040 thumbnail Immucillin_H.svg?width=300.
- Q410040 wikiPageExternalLink 856.
- Q410040 wikiPageWikiLink Q1088156.
- Q410040 wikiPageWikiLink Q1661937.
- Q410040 wikiPageWikiLink Q2030894.
- Q410040 wikiPageWikiLink Q30612.
- Q410040 wikiPageWikiLink Q4914611.
- Q410040 wikiPageWikiLink Q7921864.
- Q410040 wikiPageWikiLink Q824258.
- Q410040 wikiPageWikiLink Q8431759.
- Q410040 wikiPageWikiLink Q9622264.
- Q410040 iupacname "7".
- Q410040 type ChemicalCompound.
- Q410040 type ChemicalSubstance.
- Q410040 type ChemicalObject.
- Q410040 type Thing.
- Q410040 type Q11173.
- Q410040 comment "Forodesine (INN; also known as Immucillin H) is a transition-state analog inhibitor of purine nucleoside phosphorylase under development for the treatment of relapsed B-cell chronic lymphocytic leukemiaImmucillin H was originally discovered by Vern Schramm's laboratory at the Albert Einstein College of Medicine in New York and Industrial Research Limited in New Zealand.Forodesine is being developed by BioCryst Pharmaceuticals as Fodosine. As of 2008, it is currently in phase II clinical trials.".
- Q410040 label "Forodesine".
- Q410040 depiction Immucillin_H.svg.